Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradenitis Suppurativa Patients Versus Tetracycline Derivative

NCT05821478 is registered in ClinicalTrials.gov with Institut Pasteur as lead sponsor.

NCT NCT05821478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05821478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradenitis Suppurativa Patients Versus Tetracycline Derivative
Lead sponsor
Institut Pasteur
Phase
Phase 3
Overall status
Recruiting
Start date
May 22, 2025
Completion date
February 27, 2028
Enrollment
92 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa